Clinuvel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CUVL and other ETFs, options, and stocks.About CUVL
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug.
CEOPhilippe Jacques Wolgen
CEOPhilippe Jacques Wolgen
Employees—
Employees—
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded1999
Founded1999
Employees—
Employees—
CUVL Key Statistics
Market cap300.05M
Market cap300.05M
Price-Earnings ratio13.40
Price-Earnings ratio13.40
Dividend yield0.42%
Dividend yield0.42%
Average volume16.84K
Average volume16.84K
High today$6.42
High today$6.42
Low today$5.95
Low today$5.95
Open price$6.00
Open price$6.00
Volume42.86K
Volume42.86K
52 Week high$8.92
52 Week high$8.92
52 Week low$5.95
52 Week low$5.95
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
42.9%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.